Impact of the Brain-Derived Neurotrophic Factor Val66Met Polymorphism on Levels of Hippocampal N-Acetyl-Aspartate Assessed by Magnetic Resonance Spectroscopic Imaging at 3 Tesla
- 1 November 2008
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 64 (10) , 856-862
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health
This publication has 70 references indexed in Scilit:
- Hippocampal N-Acetylaspartate Concentration and Response to Riluzole in Generalized Anxiety DisorderBiological Psychiatry, 2008
- Role of the brain‐derived neurotrophic factor at glutamatergic synapsesBritish Journal of Pharmacology, 2008
- Cognitive and Magnetic Resonance Imaging Brain Morphometric Correlates of Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism in Patients With Schizophrenia and Healthy VolunteersArchives of General Psychiatry, 2006
- Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependenceAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006
- Effect of the BDNF Val66Met genotype on episodic memory in schizophreniaSchizophrenia Research, 2005
- Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populationsHuman Molecular Genetics, 2004
- Neuronal and glial metabolite content of the epileptogenic human hippocampusAnnals of Neurology, 2002
- Dual Voxel Proton Magnetic Resonance Spectroscopy in the Healthy Elderly: Subcortical-Frontal Axonal N-Acetylaspartate Levels Are Correlated with Fluid Cognitive Abilities Independent of Structural Brain ChangesNeuroImage, 2000
- Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brainProceedings Of The Royal Society B-Biological Sciences, 1999
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990